{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:20:12Z","timestamp":1773015612425,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine","doi-asserted-by":"crossref","award":["2022ZYLCYJ04-1"],"award-info":[{"award-number":["2022ZYLCYJ04-1"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>New drugs are needed for coronavirus disease 2019 (COVID-19).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a randomized, open-label, positive-drug parallel-controlled trial to evaluate Jieji Xuanfei Chuyi granules (JJXFCY), a Chinese patent medicine, administered within 7 days of the onset of symptoms of mild-to-moderate, laboratory-confirmed COVID-19 in adults. Participants (n\u2005=\u2005120) received JJXFCY or Lianhua Qingwen granules (LHQW), as control, 3 times daily. The primary outcome was the time for negative reverse transcription-PCR severe acute respiratory syndrome coronavirus 2 test and symptom relief after 7 days of treatment. The primary safety end point was adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Baseline characteristics were mostly similar in the JJXFCY and LHQW groups. After 7 days of treatment, clinical symptoms were relieved in both groups to a certain extent. Fever, nausea, vomiting, and sticky stool disappeared on day 7. After 15 days, cough, sputum, and nasal congestion were mainly observed. After 28 days, cough, shortness of breath, phlegm, and runny nose still existed in some subjects. No deaths were observed. Adverse events occurred in 21.7% (13\/60) and 15% (9\/60) of JJXFCY and LHQW groups, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>JJXFCY has therapeutic effects in treating mild COVID-19 cases. It reduced the persistence of COVID-19 symptoms, improved outcomes, and reduced the risk of hospitalization or death in adults with COVID-19.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041740","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T22:08:45Z","timestamp":1743372525000},"page":"e41740","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Jieji Xuanfei Chuyi granules in the treatment of COVID-19: A randomized, open-label, parallel-controlled clinical trial"],"prefix":"10.1097","volume":"104","author":[{"given":"Zhiyu","family":"Tian","sequence":"first","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3809-7260","authenticated-orcid":false,"given":"Li","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Respiratory, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzi","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Respiratory, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaodan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Respiratory, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Ding","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Respiratory, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghua","family":"Cao","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250328","first-page":"100592","article-title":"Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.","volume":"29","author":"Chen","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"R2-20250328","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.7150\/ijbs.76699","article-title":"Traditional Chinese medicine JingYinGuBiao formula therapy improves the negative conversion rate of SARS-CoV2 in patients with mild COVID-19.","volume":"18","author":"Chen","year":"2022","journal-title":"Int J Biol Sci"},{"key":"R3-20250328","doi-asserted-by":"crossref","first-page":"153242","DOI":"10.1016\/j.phymed.2020.153242","article-title":"Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial.","volume":"85","author":"Hu","year":"2021","journal-title":"Phytomedicine"},{"key":"R4-20250328","doi-asserted-by":"crossref","first-page":"153531","DOI":"10.1016\/j.phymed.2021.153531","article-title":"Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: a national retrospective registry study.","volume":"85","author":"Zhang","year":"2021","journal-title":"Phytomedicine"},{"key":"R5-20250328","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.3390\/ijerph17218155","article-title":"COVID-19 pandemic: epidemiology, etiology, conventional and non-conventional therapies.","volume":"17","author":"Rauf","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R6-20250328","first-page":"803","article-title":"Shugan Jieyu capsule improve sleep and emotional disorder in coronavirus disease 2019 convalescence patients: a randomized, double-blind, placebo-controlled trial.","volume":"42","author":"Xuedong","year":"2022","journal-title":"J Tradit Chin Med"},{"key":"R7-20250328","doi-asserted-by":"crossref","first-page":"154496","DOI":"10.1016\/j.phymed.2022.154496","article-title":"Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019.","volume":"108","author":"Chen","year":"2023","journal-title":"Phytomedicine"},{"key":"R8-20250328","first-page":"140","article-title":"Effects of Shengmai Yin on pulmonary and cardiac function in coronavirus disease 2019 convalescent patients with cardiopulmonary symptoms: a randomized, double blind, multicenter control trial.","volume":"43","author":"Xuedong","year":"2023","journal-title":"J Tradit Chin Med"},{"key":"R9-20250328","first-page":"234","article-title":"Randomized controlled study of a diagnosis and treatment plan for moderate coronavirus disease 2019 that integrates Traditional Chinese and Western Medicine.","volume":"42","author":"Wenguang","year":"2022","journal-title":"J Tradit Chin Med"},{"key":"R10-20250328","first-page":"3876","article-title":"Exploration of Chaige Jieji decoction formula syndromes based on severe cases of critical care and its application for acute exogenous fever and nosocomial infection.","volume":"44","author":"Xiong","year":"2019","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R11-20250328","doi-asserted-by":"crossref","first-page":"e23284","DOI":"10.1097\/MD.0000000000023284","article-title":"Efficacy and safety of Maxing Shigan decoction in the treatment of chronic obstructive pulmonary disease: a protocol for a systematic review and meta-analysis.","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R12-20250328","doi-asserted-by":"crossref","first-page":"113854","DOI":"10.1016\/j.jep.2021.113854","article-title":"Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.","volume":"271","author":"Li","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"R13-20250328","first-page":"5872","article-title":"Effect of Maxing Shigan decoction and dissembled prescriptions against airway inflammation in RSV-aggravated asthma and mechanism of regulating TRPV1.","volume":"47","author":"Li","year":"2022","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R14-20250328","doi-asserted-by":"crossref","first-page":"1028171","DOI":"10.3389\/fmed.2022.1028171","article-title":"Application of Jiawei Maxing Shigan Tang in the treatment of COVID-19: an observational study.","volume":"9","author":"Wu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R15-20250328","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3389\/fphar.2020.01066","article-title":"Chinese patent medicines in the treatment of coronavirus disease 2019 (COVID-19) in China.","volume":"11","author":"Zhuang","year":"2020","journal-title":"Front Pharmacol"},{"key":"R16-20250328","doi-asserted-by":"crossref","first-page":"105126","DOI":"10.1016\/j.phrs.2020.105126","article-title":"Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial.","volume":"161","author":"Xiao","year":"2020","journal-title":"Pharmacol Res"},{"key":"R17-20250328","doi-asserted-by":"crossref","first-page":"1044770","DOI":"10.3389\/fcimb.2022.1044770","article-title":"Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival.","volume":"12","author":"Cao","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R18-20250328","first-page":"9617429","article-title":"Lianhua Qingwen capsules reduced the rate of severity in patients with COVID-19: a system review and meta-analysis of randomized controlled trials.","volume":"2022","author":"Shi","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"R21-20250328","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3349\/ymj.2022.63.8.790","article-title":"Clinical characteristics of patients who contracted the SARS-CoV-2 omicron variant from an outbreak in a single hospital.","volume":"63","author":"Sohn","year":"2022","journal-title":"Yonsei Med J"},{"key":"R22-20250328","doi-asserted-by":"crossref","first-page":"05032","DOI":"10.7189\/jogh.12.05032","article-title":"COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar.","volume":"12","author":"Butt","year":"2022","journal-title":"J Glob Health"},{"key":"R23-20250328","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"R24-20250328","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41591-022-01816-0","article-title":"Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.","volume":"28","author":"Puhach","year":"2022","journal-title":"Nat Med"},{"key":"R25-20250328","first-page":"2022.01.26.22269927","article-title":"A quick displacement of the SARS-CoV-2 variant Delta with Omicron: unprecedented spike in COVID-19 cases associated with fewer admissions and comparable upper respiratory viral loads.","author":"Fall","year":"2022","journal-title":"medRxiv [Preprint]"},{"key":"R26-20250328","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.pharmthera.2021.107843","article-title":"Traditional Chinese medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms.","volume":"225","author":"Huang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R27-20250328","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"R28-20250328","first-page":"212","article-title":"Epidemiological features of 105 patients infected with the COVID-19.","volume":"113","author":"Shi","year":"2021","journal-title":"J Natl Med Assoc"},{"key":"R29-20250328","doi-asserted-by":"crossref","first-page":"e012328","DOI":"10.1136\/bmjgh-2023-012328","article-title":"Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis.","volume":"8","author":"Relan","year":"2023","journal-title":"BMJ Glob Health"},{"key":"R30-20250328","doi-asserted-by":"crossref","first-page":"e24332","DOI":"10.1097\/MD.0000000000024332","article-title":"Clinical features and risk factors for severe-critically ill COVID-19 adult patients in Jiangsu, China: a multiple-centered, retrospective study.","volume":"100","author":"Zhao","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R31-20250328","doi-asserted-by":"crossref","first-page":"1149795","DOI":"10.3389\/fpubh.2023.1149795","article-title":"Prevalence of symptoms, comorbidities, and reinfections in individuals infected with wild-type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.","volume":"11","author":"Pe\u00f1a Rodr\u00edguez","year":"2023","journal-title":"Front Public Health"},{"key":"R32-20250328","doi-asserted-by":"crossref","first-page":"105127","DOI":"10.1016\/j.phrs.2020.105127","article-title":"Hanshiyi Formula, a medicine for SARS-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: a cohort study.","volume":"161","author":"Tian","year":"2020","journal-title":"Pharmacol Res"},{"key":"R33-20250328","first-page":"90","article-title":"TCM and western medicine: diagnosis and treatment of novel coronavirus pneumonia, a case study.","volume":"29","author":"Xu","year":"2023","journal-title":"Altern Ther Health Med"},{"key":"R34-20250328","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1016\/j.apsb.2021.09.008","article-title":"Traditional Chinese medicine in COVID-19.","volume":"11","author":"Lyu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"R35-20250328","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1007\/s40615-023-01714-2","article-title":"High prevalence of diabetes among hospitalized COVID-19 minority patients: data from a single tertiary hospital.","volume":"11","author":"Ashktorab","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"key":"R36-20250328","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.14336\/AD.2021.0906","article-title":"Effectiveness and safety of traditional Chinese medicine in treating COVID-19: clinical evidence from China.","volume":"12","author":"Xing","year":"2021","journal-title":"Aging Dis"},{"key":"R37-20250328","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s11684-020-0757-x","article-title":"Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19.","volume":"14","author":"Ni","year":"2020","journal-title":"Front Med"},{"key":"R38-20250328","doi-asserted-by":"crossref","first-page":"e0256429","DOI":"10.1371\/journal.pone.0256429","article-title":"Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: a systematic review and meta-analysis.","volume":"16","author":"Du","year":"2021","journal-title":"PLoS One"},{"key":"R39-20250328","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1080\/22221751.2022.2078230","article-title":"An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants.","volume":"11","author":"Shen","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"R40-20250328","doi-asserted-by":"crossref","first-page":"617659","DOI":"10.3389\/fmed.2021.617659","article-title":"Understanding COVID-19 in Wuhan from the perspective of cold-dampness: clinical evidences and mechanisms.","volume":"8","author":"Zheng","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R41-20250328","first-page":"2993","article-title":"Large-scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules.","volume":"45","author":"Yan","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R42-20250328","first-page":"11","article-title":"Study on the value of tradition Chinese medicine treatment for COVID-19 by the view of Jiangxia Cabin Hospital.","volume":"52","author":"Shi","year":"2020","journal-title":"Jiangsu J Tradit Chin Med"},{"key":"R43-20250328","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.apsb.2020.06.009","article-title":"Combating COVID-19 with integrated traditional Chinese and Western medicine in China.","volume":"10","author":"Ni","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"R44-20250328","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1142\/S0192415X22500379","article-title":"Traditional Chinese medicine for COVID-19: a network meta-analysis and systematic review.","volume":"50","author":"Ji","year":"2022","journal-title":"Am J Chin Med"},{"key":"R45-20250328","doi-asserted-by":"crossref","first-page":"105056","DOI":"10.1016\/j.phrs.2020.105056","article-title":"Chinese herbal medicine for coronavirus disease 2019: a systematic review and meta-analysis.","volume":"160","author":"Xiong","year":"2020","journal-title":"Pharmacol Res"},{"key":"R46-20250328","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape.","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T22:10:29Z","timestamp":1743372629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041740","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}